Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ELN.F
- Price
- -
- Stock movement down
- -0.01 (-16.67%)
- Company name
- Elanix Biotechnologies AG
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 404.05K
- Ent value
- 2.96M
- Price/Sales
- 12.27
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -66.67%
- 3 year return
- -64.53%
- 5 year return
- -55.58%
- 10 year return
- -25.89%
Last updated: 2024-12-17
DIVIDENDS
ELN.F does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 12.27 |
| Price to Book | - |
| EV to Sales | 89.90 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 8.08M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 32.94K |
| Gross profit (TTM) | -108.51K |
| Operating income (TTM) | -2.37M |
| Net income (TTM) | -2.91M |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -329.41% |
| Operating margin (TTM) | -7198.02% |
| Profit margin (TTM) | -8836.05% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | NaNB |
| Net receivables | NaNB |
| Total current assets | NaNB |
| Goodwill | NaNB |
| Intangible assets | NaNB |
| Property, plant and equipment | NaNB |
| Total assets | NaNB |
| Accounts payable | NaNB |
| Short/Current long term debt | NaNB |
| Total current liabilities | NaNB |
| Total liabilities | NaNB |
| Shareholder's equity | NaNB |
| Net tangible assets | NaNB |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -302.36K |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -302.36K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -497.36% |
| Return on Invested Capital | 144.71% |
| Cash Return on Invested Capital | 15.03% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ELN.F | S&P500 | |
| Current price drop from All-time high | -100.00% | -6.47% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 30 May 2023 | 9 Mar 2009 |
| Avg drop from high | -96.79% | -11.07% |
| Avg time to new high | 6085 days | 12 days |
| Max time to new high | 6084 days | 1805 days |
COMPANY DETAILS
Marketcap
404.05K
Marketcap category
Small-cap
Description
Elanix Biotechnologies AG, a tissue regeneration company, engages in the development and commercialization of products for acute wound care. The company is based in Frankfurt am Main, Germany.
Employees
6
Investor relations
-
SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found